The greatest biomedical research organisation in the world, the National Institutes of Health, Near Patient Molecular Solutions testing produces prompt care and enables quick therapy for the patient. The National Institutes of Health contends that enabling clinicians to make decisions at the Near Patient Molecular Solutions has the potential to significantly impact the delivery of healthcare and to address the obstacles of health disparities" and that the continual creation of adaptable diagnostic and surveillance devices for POC testing could lead to "the achievement of a potential shift from curative medicine to predictive, individualised, and preemptive medicine.

Near Patient Molecular Solutions for diabetes further improves screening, and new research indicates that HbA1c might be the most accurate way to detect people with undetected prediabetes and diabetes.